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A. Bone structure and properties 
1. Function 
Bone, the main supporting system of vertebrates, is defined as a “rigid body tissue 
consisting of cells embedded in an abundant, hard intercellular material. The two 
principal components of this material, collagen and calcium phosphate, distinguish 
bone from such other hard tissues as chitin, enamel, and shell. Bone tissue makes 
up the individual bones of the human skeletal system and the skeletons of other 
vertebrates.” (Encyclopedia Britannica) 
In more detail, bone is a highly vascularized and mineralized connective tissue, which 
together with cartilage, tendons and ligaments constitutes the skeletal system. The 
functions of bone in mammals include (i) structural support for mechanical actions as 
locomotion, (ii) protection of vital organs and soft tissues, (iii) site of 
hematopoiesis (Taichman 2005), and (iv) reservoir of calcium and phosphate (Clarke 
2008).  
Bone is a specialized bi-phasic connective tissue with nonhomogeneous, anisotropic 
mechanical properties. The two phases consist of organic (30 wt-%) and inorganic 
(60 wt-%) components and are completed by 10 wt-% of water. The distinct 
composition and structure of bone leads to functionally adapted mechanical 
properties as ductility, brittleness and viscoelasticity. Moreover, the ultimate 
compressive and tensile strengths of bone are in the range of 100-200 MPa and 
50-130 MPa, respectively (Keaveny et al. 2004; Weiner & Wagner 1998). 
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2. Bone anatomy 
2.1. Anatomical structure  
Bone is classified according to its gross anatomy into flat, long, short or irregular 
bones. The principle function of flat bones, e.g. skull, pelvis, scapula, is either 
extensive protection of underlying tissues and organs or the provision of large 
surface in order to facilitate muscle and tendon attachment. Flat bones are composed 
of a three-layered structure with two thin layers of compact bone enclosing an in 
thickness variable layer of cancellous bone. The void within the cancellous bone is 
filled with bone marrow giving rise to most of the red blood cells in adults (Clarke 
2008).  
Long bones are found in the limbs consisting of a diaphysis (body or shaft) and two 
extremities. The diaphysis has a cylindrical shape, with a central cavity named 
medullary canal. As for flat bones, the medullary canal is filled with bone marrow. The 
wall of the diaphysis consists of dense, compact bone getting spongier towards the 
medullary cavity. The extremities of long bones are expanded in order to allow for 
both articulation and muscular attachment. They consist of cancellous bone covered 
by a thin layer of compact bone. The development of the extremities is initiated by 
separate ossification centers termed epiphysis. Long bones, as for example the 
femur, are curved in two planes accounting for their high strength (Gray et al. 1973). 
Examples for short and irregular bones include the patellae and the vertebrae, 
respectively. 
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Figure 1 The seven levels of bone hierarchy (Ritchie 2011). 
2.2. Hierarchical structure  
The bone tissue is build up in a hierarchical structure comprised of up to seven levels 
of organization (Figure 1). As for all biological substances, the building blocks of bone 
are amino acids in the form of 
polypeptide strands. Collagen 
molecules (tropocollagen) are 
mainly consisting of the amino 
acid glycine. Tropocollagen is 
a subunit of larger collagen 
aggregates (collagen fibrils) 
and is made up of three 
polypeptide strands organized 
in a triple helix. Each collagen 
molecule is arranged parallel 
with the other molecules head 
to tail. This arrangement 
leaves a gap of approximately 
40 nm between each 
molecule. This gap is the 
starting point for 
mineralization, which further 
extends to other intramolecular 
spaces leading to mineralized 
collagen fibrils arranged in fibril 
arrays. The ceramic 
crystalline-type mineral consists of spindle- or plate-shaped crystals of carbonated 
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hydroxyapatite (Ca10(PO4)6(OH)2). In order to facilitate the high tensile and 
compressive strength of bone, fibril arrays are stacked in a non-parallel manner 
giving rise to distinct structure as osteons (cylindrical motifs of fibril arrays), the 
Haversian canals (HC, longitudinal canal within an osteon) and the Volkmann canals 
(transversal canals connecting HC) (Keaveny et al. 2004) (Figure 2).  
Besides the structural components of bone, organic components are important for the 
maintenance and the function of bone. Solely 2% of the organic fraction is made up 
by cells (osteoblasts, osteocytes, osteoclasts), growth factors [e.g. fibroblast growth 
factors (FGFs), platelet-derived growth factors (PDGFs), transforming growth factor-
beta (TGF-β) and bone morphogenic proteins (BMPs)] and cytokines [e.g. Interleukin 
1-beta (IL-1b), Interleukin 6 (IL-6), tumor necrosis factor (TNF)] (de Vernejoul et al. 
1993). About 90% of the organic extracellular matrix (ECM) is composed of type-I 
collagen fibrils. The remaining fraction composes proteoglycans and non-collagenous 
proteins, such as bone sialoprotein II (BSP), osteocalcin (OC), and osteopontin 
(= bone sialoprotein I, OP) (Manolagas & Jilka 1995; Post et al. 2010). 
Figure 2 The osteon units of bone. 
The osteon is made up of osteocyte lacunae (OL), osteocyte canaliculi (OC), Haversian 
canals (HC) and Volkmann canals (VC) (OpenStax College 2014). 
OC 
OL 
VC 
HC 
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The major cell types in the bone tissue are osteoblasts, osteocytes and osteoclasts. 
Osteoblasts are bone forming cells derived from local pluripotent mesenchymal 
stromal cells (MSC). These MSC are originating from either the bone marrow or the 
periosteum. The functions of osteoblasts include synthesis and secretion of non-
mineralized bone matrix containing alkaline phosphatase, type-I collagen, 
osteonectin and osteocalcin and the regulation of osteoclast function. Lining the bone 
surface, osteoblasts are gradually entrapped in the bone matrix that they secrete 
resulting in a dramatic decrease of their metabolic activity. These entrapped, stellate-
shaped cells are fully differentiated mature bone cells (osteocytes) (Bonewald 2011; 
Knothe Tate et al. 2004). Osteocytes are the most abundant cell type in bone tissue 
accounting for about 90% of cells in the mature skeleton. Inter-osteocytic 
communication and the communication between osteocytes and bone lining cells are 
carried out with the help of the well-developed canalicular network consisting of 
extended cytoplasmic processes. Though osteocytes are relatively inert cells, they 
are involved in the maintenance of bone, the homeostasis of calcium and 
phosphorous as well as signal transmission via their processes (Knothe Tate et al. 
2004; Noble 2008; Bonewald 2011).  
Osteoclasts originate from hematopoietic cells of the macrophage lineage. Through 
the fusion of monocyte progenitors they form mature multinuclear cells. The main 
function of osteoclasts is resorption of bone (Nordin & Frankel 2001). The well 
organized and orchestrated interplay of the previously describe cell types is crucial 
for bone homeostasis, remodeling and repair. 
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3. Bone formation 
In the early stages of embryonic development, the embryo’s skeleton consists of 
hyaline cartilage. By the sixth or seventh week of embryonic life, the actual process 
of bone development begins. Bone formation or ossification during the fetal stage of 
development occurs by two distinct processes: intramembranous ossification and 
endochondral ossification. 
3.1. Intramembranous ossification 
Intramembranous ossification occurs during formation of the flat bones of the skull, 
the flat part of the clavicle and during primary fracture healing. In this ossification 
process, compact and spongy bone is formed by direct bone matrix deposition. The 
process begins through condensation of MSC, which then differentiate into 
osteoblasts (Figure 3a). The osteoblasts secrete type-I collagen fibrils that make up 
the osteoid. The osteoid, an uncalcified matrix, calcifies within a few days through the 
deposition of mineral salts forming calcified bone matrix (Figure 3b). During the next 
step, trabeculae are formed through the random creation of osteoids around blood 
vessels. Simultaneously, the periosteum is formed through condensation of the blood 
vessels surrounding the bone (Figure 3c). Lastly, the development of red bone 
marrow and compact bone through thickening of the trabeculae occurs (Figure 3d). 
Intramembranous ossification is a process that begins during fetal development and 
continues throughout adolescence. At birth, the skull, the sutures of the skull and 
clavicles are not fully ossified allowing for deformation of the skull and shoulders 
during passage through the birth canal (Karaplis 2008; Franz-Odendaal 2011).  
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Figure 3 Intramembranous ossification. 
(a) Mesenchymal stromal cell condensation and osteogenic differentiation. (b) Osteoid formation. 
(c) Trabeculae and periosteum formation. (d) Compact bone and bone marrow develops (Browne 
2013). 
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3.2. Endochondral ossification 
Endochondral ossification occurs in most of the bones, especially in long bones, in 
vertebrates and during secondary (non-rigid) fracture healing. During this process, 
hyaline cartilage is subsequently replaced by bone. The cartilage intermediate serves 
as a template in terms of size and shape (Kronenberg 2003). Endochondral 
ossification begins with the development and growth of the cartilage “model” through 
condensation of mesenchymal cells and their subsequent differentiation into 
chondrocytes (Figure 4a). Due to low oxygen conditions, chondrocytes differentiate 
further into hypertrophic chondrocytes and start to mineralize their surrounding 
matrix. Through the mineralized matrix nutrients can no longer reach the 
chondrocytes leading to cell death and the disintegration of the surrounding matrix 
(Figure 4b). Blood vessels invade the resulting spaces carrying osteogenic and 
osteo- and chondroclastic cells, thereby forming the primary ossification center. At 
the same time transformation of the perichondrium towards the periosteum is initiated 
leading to the formation of the periosteal collar (Figure 4c). During this ossification 
step, cartilage continues to grow and chondrocytes proliferate at the ends of the bone 
(epiphysis) increasing bone length (Figure 4d). This process occurs along with the 
replacement of cartilage by bone in the diaphysis leaving cartilage remanence at the 
joint surfaces (articular cartilage). Additionally, the epiphyseal growth plate remains 
between the diaphysis and epiphysis. The same sequence of events occurs in the 
epiphyseal regions leading to secondary ossification centers (Figure 4e). Lastly, the 
creation of the epiphysis is finalized including the joint surface and the epiphyseal 
(growth) plate (Figure 4f) (Gawlitta et al. 2010; Mackie et al. 2008; Mackie et al. 
2011). 
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Figure 4 Endochondral ossification. 
(a) Mesenchymal stromal cell condensation and chondrogenic differentiation. (b) Cartilage 
calcification and perichondrium formation. (c) Vascular invasion and formation of primary 
ossification center. (d) Cartilage growth at the ends of the bone. (e) Secondary ossification centers 
develop. (f)  articular cartilage and epiphyseal plate remain uncalcified (Browne 2013). 
 
General Introduction  
12 
4. Bone remodeling 
Bone is a dynamic tissue that is remodeled in response to the mechanical forces, a 
phenomenon described by Wolff's Law (Wolff 1892). This phenomenon is a balanced 
process of bone resorption and formation, which is choreographed spatially and 
temporally. Tight coupling of these processes is required to maintain the skeleton 
(Hauge et al. 2001). A key trigger of bone remodeling is the local mechanical 
environment. In particular load bearing induces fluid shear stress within the 
canalicular network, which leads to an onset of osteocyte signaling and therewith 
either an activated or repressed bone formation by osteoblasts (Chen et al. 2010). 
These facts suggest that mechanical stimuli are among the most potent factors acting 
in the processes of bone remodeling (Chen et al. 2010). Ultimately bone remodeling 
is mediated by the cells related to the bone tissue: osteocytes, being the putative 
mechanosensors; osteoblasts, depositing new bone matrix; osteoclasts, resorbing 
fatigue bone matrix; and their progenitors (osteoblasts, mesenchymal stromal cells 
and mononuclear cells, respectively) (Figure 5). 
Figure 5 Bone remodeling phases (Anon 2014). 
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B. Bone fracture healing 
Fracture healing is a natural, physiological process leading to the repair of bone 
fractures. It is a highly orchestrated sequence recapitulating the processes of bone 
formation. Unlike soft tissue healing, which leads to scar formation, bone fracture 
healing results in functional tissue regeneration (Gerstenfeld et al. 2003; Behonick et 
al. 2007; Marsell & Einhorn 2011). As for bone formation, fracture healing occurs in 
two distinct processes: primary and secondary fracture healing. Stable fractures 
(interfragmentary strain <2%) heal along the primary (direct) fracture healing process 
(Shapiro 1988), whereas the majority of fractures heals along the secondary (indirect) 
fracture healing process. 
1. Primary fracture healing 
Primary fracture healing directly aims at re-establishing the anatomically correct and 
biomechanically competent lamellar bone structure with minimal or no formation of a 
fracture callus. This attempt is solely functioning when the ends of fractured bone are 
in direct contact and an intact vasculature is available (Sfeir et al. 2005). Due to this 
fact, primary healing occurs only after rigid surgical fixation or unicortical fractures 
(partial fracture of the bone). The process of primary fracture healing is initiated and 
lead by a cutting cone comprising osteoclasts resorbing bone fragments at the tip of 
the cone followed by osteoblasts laying down new bone matrix (Marsell & Einhorn 
2011). 
2. Secondary fracture healing 
Secondary fracture healing is a process that resembles certain aspects of skeletal 
development and growth following the endochondral route. The process is generally 
divided into 4 phases (Figure 6): a) hemorrhage and inflammation; b) soft callus 
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formation; c) hard callus formation; d) callus remodeling (Sfeir et al. 2005; Schindeler 
et al. 2008). These phases are not strictly separated; instead there is often a 
significant overlap between them. The key features of secondary fracture healing are 
ossification of the cartilaginous (soft) callus and its complete remodeling leading to 
full regeneration and re-establishment of the bone functionality (Gerstenfeld et al. 
2003). 
a) Hemorrhage and inflammation 
A fracture leads to the disruption of the local tissue integrity including the vasculature, 
soft tissues and the bone marrow. The bleeding develops into a hematoma, which 
activates platelets, plasma components, macrophages, and other inflammatory cells. 
These cells secrete cytokines (interleukin-1 (IL-1), IL-6, IL-11 and IL-18) and growth 
factors (e.g. transforming growth factors-β (TGF- β), tumor necrosis factor-α (TNF-α)) 
and thereby enable the migration and invasion of multipotent MSC into the 
granulation tissue (Figure 6a) (Gerstenfeld et al. 2003; Sfeir et al. 2005; Schindeler et 
Figure 6 Secondary fracture healing. 
(a) Hemorrhage and inflammation. (b) Soft callus formation. (c) Hard callus formation. 
(d) Callus remodeling (OpenStaxCollege 2014). 
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al. 2008). Furthermore, hypoxia induces angiogenesis through the hypoxia inducible 
factor 1 alpha (HIF1α) pathway (Wang et al. 2007; Wan et al. 2008). 
b) Soft callus formation 
Due to fracture instability, a soft callus, both internally and externally, is formed within 
2 weeks post fracture. Mesenchymal progenitors are activated by signaling 
molecules (e.g. IL-6, TNFα) and recruited to the fracture site (Raheja et al. 2011). 
The sources of osteoprogenitors are mainly the bone marrow and the periosteum, but 
also include the circulation, the vasculature, and surrounding local tissues. The 
recruited cells differentiate towards osteoblasts and chondrocytes and deposit ECM. 
The semi-rigid callus provides mechanical stability and -as for endochondral bone 
formation- depicts a template for the bony callus formed in the subsequent phase. 
The chondrocytes replace the granulation tissue by a synthesized cartilaginous 
matrix mainly consisting of type-II collagen. As soon as the entire granulation tissue 
is replaced, chondrocytes undergo hypertrophy, mineralize the cartilaginous 
template, and undergo apoptosis. Following, the mineralized soft callus is 
vascularized through invasion of vascular endothelial cells and capillary ingrowth 
(Figure 6b) (Sfeir et al. 2005; Schindeler et al. 2008).  
c) Hard callus formation  
This phase demonstrates the most active period of osteogenesis. Osteoblasts reach 
their maximal activity and in collaboration with other cell types gradually replace the 
mineralized cartilaginous template with unordered, woven bone matrix. Due to the 
stability gained through the mineralization of the internal callus, the external callus is 
resorbed. To ensure full maturation of osteoblasts an increased oxygen tension is 
required. Therefore vascularization of the callus is crucial in order to develop the 
formation of a hard callus (Figure 6c) (Sfeir et al. 2005; Schindeler et al. 2008). 
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d) Callus remodeling 
The final phase of the secondary fracture healing process aims at the entire 
remodeling of the woven bone towards cortical and/or trabecular bone. It resembles 
the bone remodeling process including the involvement of osteoblasts and 
osteoclasts in a spatially and temporally choreographed manner (Figure 6d) (Sfeir et 
al. 2005; Schindeler et al. 2008). 
3. Parameters affecting bone fracture healing 
Bone fracture healing is a highly complex and tightly regulated process. It is 
influenced by many factors including mechanical stability (severity and location of 
fracture), environmental cues (vascularization, availability of growth factors and 
cytokines), nutrient supply, and medication. The key process within the progression 
of fracture healing is callus remodeling (Schindeler et al. 2008). During the process of 
fracture healing numerous cell types (e.g. osteoblasts, MSC, chondrocytes, 
inflammatory cells, macrophages, etc.) are actively involved and are responding to 
the given environmental cues. These cues comprising biochemical [e.g. insulin-like 
growth factor (IGF)-I, IGF-II, TGF-β, IL-1β, IL-6 (Caetano-Lopes et al. 2011; Lange et 
al. 2010)] and biomechanical (deformation of formed tissue, fluid flow, biophysical 
loads) signals control tissue differentiation, cell proliferation, ECM synthesis as well 
as tissue remodeling within the fracture callus (Schmidmaier et al. 2003; Ethier & 
Simmons 2007). 
The presence and timing of the regulatory system of biochemical cues direct the 
healing processes during the different stages of bone fracture healing. The signaling 
molecules involved are classified into three groups: pro-inflammatory cytokines, 
TGF-β superfamily and other growth factors, and angiogenic factors (Dimitriou et al. 
2005; Tsiridis et al. 2007). The pro-inflammatory cytokines (e.g. IL-1, Il-6, TNF-α) are 
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secreted by macrophages, other inflammatory cells, and by cells of mesenchymal 
origin during the initial stages of fracture healing. Besides their function in the 
recruitment of inflammatory cells, cytokines play a crucial role in the regulation of 
ECM synthesis, stimulation of neo-vascularization and homing of MSC (Dimitriou et 
al. 2005; Tsiridis et al. 2007). The members of the TGF-β superfamily (e.g. TGF-β, 
IGF-I and –II, platelet-derived growth factor (PDGF), bone morphogenetic proteins 
(BMPs), etc.) are involved in the regulation of proliferation and differentiation of MSC 
towards chondrocytes and osteoblasts (Bostrom et al. 1995; Dimitriou et al. 2005; 
Phillips 2005) and are known to accelerate bone fracture healing (IGF-I, (Shen et al. 
2002)]. Moreover, BMPs may depict key molecules within the signaling cascade 
linking mechanical forces with biological responses (Sato et al. 1999; Rauch et al. 
2000). Angiogenic factors (e.g. vascular endothelial growth factors (VEGFs), 
angiopoetin-1 and -2, HIF-1α) are the key mediators of the fracture site 
vascularization (Dimitriou et al. 2005). 
Bone fragments, independent of the method of fracture fixation, experience a certain 
degree of motion when loads are applied determining the morphological structures of 
the fracture healing process. The “interfragmentary strain theory”  relates the tissue 
response to the mechanical environment and defines the interfragmentary strain as 
“the ratio of the relative displacement of the fracture ends versus the initial gap 
width”. This theory is an oversimplification of the actual biomechanical processes and 
biological responses. At the same time it depicts the basis for the understanding of 
the influence of biophysical stimuli on the process of fracture healing. The 
mechanical environment of fractures such as interfragmentary strain and 
rigidity of fixation has been shown to play an important role in the processes of 
fracture healing and tissue differentiation (Chao & Inoue 2003). Additionally, it 
has been demonstrated that mechanical stimulation of fractures can induce/trigger 
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their healing or alter the biological pathways involved. Crucial mechanical loading-
related parameters comprise: strain amplitude, frequency, stimulation pattern 
(loading and resting phases), fracture geometry, and direction of loading (Rand et al. 
1981; Goodship & Kenwright 1985; Aro et al. 1991; Claes et al. 1997; Park et al. 
1998; Rubin et al. 2001). These parameters have been studied both in vitro 
(Démarteau et al. 2003; Matziolis et al. 2006; Sun et al. 2010; Lujan et al. 2011; 
Puetzer et al. 2012) and in vivo (Park et al. 1998; Hente et al. 2004; Willie et al. 
2010). Nevertheless, some studies correlated local mechanical environments and 
their effects on tissue differentiation or fracture healing patterns with the tissue 
differentiation theories (Claes & Heigele 1999) using finite element modeling (FEM) 
(Prendergast 1997; Lacroix 2000; Loboa et al. 2005; Lacroix et al. 2002). These 
studies emphasize the complex processes occurring during fracture healing. In 1999, 
Claes and Heigele (Claes & Heigele 1999) hypothesized the following relations 
between strains in a fracture site and the outcome obtained during fracture 
healing (Figure 7): small strains and small hydrostatic pressures < ±0.15 MPa lead to 
direct bone formation, compressive hydrostatic pressures > 0.15 MPa lead to 
chondrogenesis and therefore endochondral ossification, and all other stimuli lead to 
connective tissue or fibrocartilage formation. However, more recently (2004) Smith-
Adaline et al. (Smith-Adaline et al. 2004) demonstrated that intermittent tensile 
strains promote endochondral ossification and compressive strains promote 
intramembranous ossification. These studies, upon others, emphasize that effects 
induced through biophysical processes during fracture healing are not entirely 
understood. 
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Figure 7 Hypothesis-based correlations between mechanical conditions and types of tissues 
generated in a fracture callus. Adopted from (Claes & Heigele 1999). 
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C. Tissue Engineering 
The origin of Tissue Engineering (TE) can be traced to Y.C. Fung, a pioneer in the 
fields of biomechanics and bioengineering. In 1985 he submitted a proposal to the 
American National Science Foundation for an engineering research center to be 
entitled "Center for the Engineering of Living Tissues”. Nevertheless, the 
understanding of TE as a unifying concept for a broad range of interdisciplinary fields 
of research can be dated back to the publication of a review paper by Robert Langer 
and Joseph P. Vacanti in 1993. Since then tissue engineering has been defined as 
“an interdisciplinary field that applies the principles of engineering and the life 
sciences toward the development of biological substitutes that restore, maintain, or 
improve tissue function” (Langer & Vacanti 1993). 
The general principle of TE includes the combined utilization of biomaterials, 
(stem) cells and signals (e.g. growth factors, mechanical stimuli), the so called “tissue 
engineering triad” (Lanza et al. 2000). This triad is used in several combinations and 
variations following the tissue engineering paradigm (Figure 8).  
Autologous cells, mainly MSC, are harvested from patient’s bone marrow, adipose or 
other tissue. They are capable of in vitro differentiation into the mesodermal cell 
lineages, like osteoblasts, chondrocytes and adipocytes. The MSC are cultured 
in vitro in monolayer cultures expanding them towards a sufficient amount of cells. 
The expanded MSC are further cultured on three-dimensional constructs, termed 
scaffolds, and additional stimuli including biochemical (growth factors, small 
molecules, etc.) and biomechanical (shear, compression, etc.) ones, are applied. 
These stimuli prime the MSC towards a desired lineage forcing them to differentiate 
and maturate. During this process a tissue specific extracellular matrix is deposited 
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and the hybrid cell-ECM-scaffold construct develops towards a functional graft. The 
engineered, functional graft is used as an “autologous” implant for the patient. 
Bone tissue engineering (BTE) aims at the development of alternatives to the 
conventional bone grafting procedure via in vitro generation of engineered, functional 
bone substitutes. When bone repair mechanisms fail, bone grafting has been shown 
to be a highly potent alternative. Bone grafting is a procedure in which bone from a 
different location is harvested in order to bridge the gap and to stimulate bone 
formation at the fracture site. The graft can be of several origins: autologous 
(patient’s own bone), allogeneic (bone from other humans), xenogeneic (bone from 
other species) or synthetic (biomaterial). Each of the mentioned origins of the bone 
Figure 8 Tissue engineering paradigm. 
Autologous (stem) cells are harvested (1) and expanded (2) in vitro. Reaching a sufficient cell 
number, cells are seeded onto a 3D scaffold (3). Further in vitro culture including biochemical as 
well as biomechanical stimuli leads to tissue formation and maturation (4). Finally, the obtained 
graft is implanted into the patient (5). 
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graft holds certain advantages (mechanical strength of the graft, availability, quality, 
etc.) and disadvantages (transmission of diseases, donor site morbidity, etc.).  
Following the tissue engineering paradigm, constructs based on autologous cells and 
synthetic biomaterials ideally could replace autologous bone grafts (van Gaalen et al. 
2008). However, BTE-derived products are just starting to enter clinical applications 
due to several limitations and challenges, such as lacking sufficient vascularization at 
the defect site, lacking FDA approval, and cost-effectiveness (Amini et al. 2012). 
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1. Biomaterials 
The first reported application of “biomaterials” dates back to 3000 B.C. In ancient 
Egypt linen threads have been used to close wounds (surgical suture). The first 
dental implant, a shell shaped to fill the defect, was placed according to carbon 
dating in 900 A.D. It was implanted in Europe and was found to be properly 
integrated into the surrounding bone (Bobbio 1972; Gentleman et al. 2009). 
According to the American National Institute of Health biomaterials can be defined as 
“any substance or combination of substances, other than drugs, synthetic or natural 
in origin, which can be used for any period of time, which augments or replaces 
partially or totally any tissue, organ or function of the body, in order to maintain or 
improve the quality of life of the individual’’ (NIH Consens Statement 1982). 
Nevertheless, this definition lacks the fact that biomaterials have to be biocompatible, 
i.e. show the ability to perform with an appropriate host response in a specific 
situation (Williams 1999). The possible host tissue reactions are used to classify 
biomaterials: (i) bio-tolerant materials (no adverse host reaction, mostly fibrous 
encapsulation), (ii) bio-active materials (trigger a desired, positive biochemical host 
response) and (iii) bio-inert materials (no biochemical response occurs) (Bergmann & 
Stumpf 2013). 
Nowadays, biomaterials are used for many applications including long- and short-
term implants, sensors, scaffolds for tissue engineering, and surgical tools and 
auxiliary material (e.g. tubes, blood bags, etc.). Biomaterials can be derived from 
natural components or synthesized using a variety of chemical approaches. Table 1 
summarizes the biomaterial classes and their applications in the biomedical field 
(Ratner et al. 1996).  
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Table 1 Classification of biomaterials (Ratner et al. 1996) 
Class of 
biomaterial 
Properties of class Examples & applications 
Metals 
mechanically strong, excellent 
electrical and thermal 
conductivity, though, ductile; 
may corrode, very dense, may 
cause allergies 
stainless steel, Ti, Ti-based alloys 
(Ti6Al4V), gold, etc.; joint 
replacements, bone plates and screws, 
used in orthopedics, oral & 
maxillofacial or cardiovascular surgery 
and as surgical tools, etc. 
Polymers 
resilient, easy to fabricate; may 
degrade, deform with time, 
mechanically weak, may provoke 
inflammatory response 
poly-ether-ether-ketone (PEEK), 
polyester, polyurethane (PUR); 
sutures, facial prosthesis, joints, blood 
vessels, etc. 
Ceramics, 
glasses and 
glass-ceramics 
very biocompatible, inert, strong 
in compression; brittle, non-
resilient, difficult to manufacture 
calcium phosphates, circonia, 
aluminum oxides; femoral head of hip 
replacement, coating of dental and 
orthopedic implants 
Natural 
materials 
biocompatible, geometry and 
composition mimics in situ 
environment; may be 
immunogenic, difficult to 
manufacture and to maintain 
constant quality 
Proteins (silk, collagen, fibrinogen, 
etc.), polysaccharides (cellulose, 
glycosaminoglycan (GAG), etc.), 
polynucleotides (DNA, RNA) ; sutures, 
bone substitute, heart valves, etc. 
Bioresorbable 
materials 
resilient, easy to fabricate; 
deform with time, mechanically 
weak 
polylactide (PLA), polyglycolide (PGA), 
polycaprolcatone (PCL), beta-tri-
calcium phosphate (β-TCP), 
magnesium; sutures, drug delivery 
device, adhesion prevention 
Composites 
strong, tailor-made; difficult to 
manufacture, biocompatibility 
wire, particle or fiber reinforced 
composites; bone cements, joint 
implants, heart valves 
Biologically 
functionalized 
materials 
biological “activation” of inert 
biomaterials; difficult to 
manufacture 
immobilized enzymes, antibodies, 
lipids, substrates; cancer treatment, 
improvement of osseointegration (BMP 
immobilization), etc. 
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As for the materials, a high degree of versatility exists for their manufacturing, 
cleaning and sterilization procedures. In the following paragraph, a short description 
of the additive manufacturing process in particular of biomaterials will be given. 
Additive manufacturing or 3D printing (3DP) is known since the 1980s. Nevertheless, 
it has traditionally been used during product development to manufacture concept 
prototypes (“rapid prototyping”) prior to production. However during the last years 
there has been increased interest to adopt the technology as a full-scale 
manufacturing solution. The technology fabricates 3D objects in a bottom-up, additive 
manner using digital computer aided design (CAD) (Chua et al. 2010). In contrast to 
conventional methods (e.g. drilling, milling, turning, etc.), where material is removed 
(subtractive processes), 3DP deposits material or fuses powdered material in 
successive steps, where thin layers finally build-up a solid 3D object. Depending on 
the materials used (metals, ceramics, polymers) different methods/technologies are 
applied to solidify the powders. These technologies include fused deposition molding 
(FDM, polymer and eutectic metals), electron beam free-form fabrication (EBF, metal 
alloys), direct metal laser sintering (DMLS, metal alloys), electron-beam melting 
(EBM, titanium alloys), selective laser sintering (SLS, thermoplastic, ceramic and 
metallic powders), selective laser melting (SLM, Figure 9, titanium alloys, stainless 
steel, aluminum), stereo-lithography (SLO, photopolymers) and others (Wong & 
Hernandez 2012). These techniques are recently employed for the production of 
complex-shaped, anatomically inspired scaffolds for TE applications. A thorough 
review regarding rapid-prototyping techniques used to fabricate scaffolds was 
published by Abdelaal and Darwish in 2013 (Abdelaal & Darwish 2013). 
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In order to overcome bone grafting-related issues, synthetic materials such as 
hydroxyapatite (HA) (Elsinger & Leal 1996), tri-calcium phosphate (TCP) (Habibovic 
et al. 2006) and their combination bi-calcium phosphate (BCP) (Daculsi et al. 1989) 
have been used clinically and for BTE-applications. Though calcium phosphate 
ceramics (e.g., HA and TCP) are mostly used for bone tissue engineering 
applications due to their osteoinductive and osteoconductive properties (Albrektsson 
& Johansson 2001; Salgado et al. 2004; Rezwan et al. 2006; Hutmacher et al. 2007), 
they generally lack tensile strength. This is required for initial load bearing and 
primary implant stability. Moreover, as bulk material, ceramics do not match the 
mechanical properties of the surrounding bone, limiting their application to non-load 
bearing situations or requiring long periods of immobilization during bone healing. 
In this thesis, two distinct biomaterials have been used to engineer bone or bone-like 
tissues and to overcome the previously mentioned limitations.  
Figure 9 Selective laser melting (Protoshape 2014). 
Selective laser melting (SLM), is an additive manufacturing technique that allows manufacturing 
prototypes using 3D CAD files. Briefly, a powder layer is selectively melted using a focused high 
energy laser. A consecutive powder layer is deposited. The process is repeated until the part is 
finalized. 
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The first scaffold, Optimaix® (Matricel GmbH, Herzogenrath, Germany), is a “natural 
material” based on faunal collagen. The collagen scaffold is cross-linked with 1-
Hydroxy-2,5-pyrrolidindion (NHS) and 1-Ethyl-3-(3 -dimethylaminopropyl)-carbodiimid 
(EDC) in order to adjust biodegradability. This scaffold is used as an in vitro model of 
a soft callus in bone fracture healing (secondary healing), following three weeks of 
chondrogenic induction of the MSC seeded scaffold. 
As a second scaffold a metallic biomaterial has been used. It is manufactured from 
pre-alloyed powder of the shape memory alloy nickel-titanium (NiTi) using selective-
laser-melting (Bormann et al. 2012). Metallic alloys allow for tuning material and 
mechanical properties towards specific medical needs (e.g., Young’s modulus). 
Especially, NiTi alloys have -for a metal- particularly low Young’s moduli (in the range 
of bone), are pseudo-elastic and have a high damping capacity (de Wild et al. 2014). 
The design of a scaffold is essential for its correct interaction with cells and its in vivo 
functionality (Lacroix et al. 2009). Here the scaffold geometry was designed 
according to geometrical specifications allowing for cell colonization and 
vascularization. These structural parameters include a well-defined porosity and 
interconnectivity to enable mass transport and vessel ingrowth, pore sizes adapted to 
the targeted tissue (Yeong et al. 2004), mechanical integrity, the possibility for 
mechanotransduction (i.e. elasticity and force transmission through the scaffold), and 
the feasibility to produce these structures within complex three- dimensional 
anatomical shapes (Hollister 2005; Rauh et al. 2011).  
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1.1. Wound healing around implants/biomaterials 
Biomaterials and implants initiate a well-defined but complex process of 
biomaterial/host interaction upon placement into a biological environment (Stanford & 
Schneider 2004). These processes follow a similar cascade as is seen in secondary 
fracture healing and wound healing. They consist of the following phases: 
(i) hemostasis, (ii) inflammatory phase, (iii) proliferative phase and (iv) remodeling 
phase (Davies 2003).  
(i) Hemostasis 
Right after implant placement, various plasma proteins (e.g. fibrin) are adsorbed onto 
the biomaterial surface. During hemostasis platelets are activated and start releasing 
growth factors (PDGF, TGF-β, FGF, etc.), which act as chemoattractants 
(Postlethwaite et al. 1987) for fibroblasts and MSC and stimulators for their cell 
division and differentiation. During the formation of the blood clot a random fibrin 
network is secreted adhering to the biomaterial surface. This network will guide MSC 
migration towards the implant surface in the later phases of wound healing. 
(ii) Inflammatory phase 
During the inflammatory phase the site of implantation is cleaned up by 
polymorphonuclear leukocytes (PML), which release reactive oxygen species (ROS) 
to kill bacteria (Segal 2005). Simultaneously, PML release collagenase, elastase and 
monocyte chemotactic protein (MCP-1). Finally, recruited macrophages migrate to 
the implant site, eliminate bacteria and debris (created during implant placement), 
and release pro-inflammatory cytokines and proteases.  
(iii) Proliferative phase 
During the previous phases many cytokines and growth factors have been released, 
which initiate the synthesis and secretion of ECM components such as collagens, 
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elastin and proteoglycans by MSC. Due to hypoxia within the implant site, the 
migration of perivascular cells towards the implant site is initiated and neo-
vascularization occurs (Pugh & Ratcliffe 2003). Furthermore, first osteoclastic bone 
resorption activity is occurring, which leads to the reduction of primary implant 
stability and the release of BMPs, TGF-β and PDGF. These factors initiate the 
differentiation of MSC towards osteoblasts, which produce woven bone matrix and 
thereby reestablish implant stability. 
(iv) Remodeling phase 
During the remodeling phase, osteoclasts and osteoblasts synergistically remodel 
woven into lamellar bone coordinated by osteocytes.  
This highly orchestrated sequence of events occurring during wound healing is 
influenced by many factors. These factors include implant related parameters, such 
as the interrelated surface characteristics (surface chemistry, roughness and 
topography), growth and systemic factors, mechanical loading and the health status 
of the patient (Anil & Anand 2011). 
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2. Mesenchymal stem or stromal cells 
Mesenchymal stem or stromal cells depict an optimal cell source for TE applications 
given their high potential to differentiate along several lineages within the germ layer. 
“Stem cells are defined as resting cells cable of asymmetric cell division to allow both 
self-renewal (preventing depletion of the stem cell pool) and the production of 
progeny cells that start proliferation and differentiation (generating one or more tissue 
types)” (Aubin 1998; Bianco et al. 2001; Muschler & Midura 2002). Those properties 
are also referred to as ‘stemness’ (Jukes et al. 2008). Due to this properties stem 
cells can provide potentially an unlimited - because in theory immortal - cell source, 
which can be differentiated into a desired cell type. Stem cells are divided into two 
main groups: embryonic and adult or somatic stem cells. Adult stem cells are 
undifferentiated cells replenishing dying cells and regenerating damaged tissues. 
They can be found in various regions of the human body such as liver, muscle, 
spleen, bone marrow, adipose tissue, placenta or the umbilical cord (Pittenger et al. 
1999). Embryonic stem cells are responsible for the fetal development and growth 
and can be isolated from the inner cell mass of blastocysts. 
To obtain functional cells specialized to fulfill a certain purpose, cells have to undergo 
cellular differentiation, a process by which a cell acquires specialized characteristics 
needed to become a tissue cell (gain of specific function), at the expense of cellular 
plasticity. During the development of an organism multiple steps of differentiation 
occur to form a complex system of tissues and different cell types out of a single 
zygote. Not only during embryogenesis, but also in adult organisms differentiation is 
a common process, particularly adult stem cells are dividing and thereby creating 
fully differentiated daughter cells (asymmetric division). This process occurs during 
tissue repair and physiological cell turnover. Cells are dramatically changed during 
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differentiation, characterized through for example changes in size, shape, metabolic 
activity or responsiveness to signals. These changes are due to highly-controlled and 
environmental-driven modifications in their gene expression profiles (Pittenger et al. 
1999). 
Bone substitutes derived from neat biomaterials lack a crucial component available in 
bone grafts: the cellular compartment. Therefore, BTE aims at recapitulating bone 
grafts through the utilization of several cell types (i.e. osteoblasts, progenitors, etc.) in 
combination with biomaterials to engineer bone tissues or substitutes, which 
contribute actively to the bone repair mechanism. Such engineered tissue are 
generated to ensure limitless supply of bone substitutes and barred disease 
transmission (Amini et al. 2012).  
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3. Signals 
As the third component of the TE triad, this chapter focuses on signals exerted 
towards MSC (e.g. growth factor, mechanical stimulus, etc.). Regulated growth 
factor/hormone release and growth factor homeostasis are key triggers during 
embryonic development and organogenesis. Therefore, using defined and controlled 
mixtures of growth factors can create a refined and controlled approach to tissue 
regeneration applications.  
Generally, growth factors are hormones regulating cellular activity. These regulatory 
effects can either stimulate or inhibit cellular proliferation, differentiation, migration, 
adhesion, apoptosis, and gene expression (Tabata 2001). Moreover, growth factors 
are secreted proteins that exert their effects on neighboring cells (paracrine) or the 
growth factor-producing cell itself (autocrine). The effect occurs through the 
interaction with specific receptors on the cell surface. Various cell types can produce 
the same growth factors that can act on multiple cell types (pleiotropism) with similar 
or various effects. Moreover, the same biological effect can be induced through 
different growth factors (redundancy). The efficacy of a growth factor on cells is 
concentration-dependent and occurs at picomolar to nanomolar concentrations 
(Ferrara & Gerber 2001). Moreover, growth factors can initiate the up- or 
downregulation of the number of cell surface receptors.  
The activity of secreted growth factors is regulated through their binding to matrix 
molecules or soluble carrier molecules thereby affecting activity and stabilization. 
Furthermore, the cellular response is influenced through the location and temporal 
expression of growth factors. Insulin-like growth factors (IGFs), bone morphogenetic 
proteins (BMPs), fibroblast growth factors (FGFs), and vascular endothelial growth 
factors (VEGFs) are examples for secreted soluble growth factors. Besides regulating 
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growth factors, the accessibility or bioavailability of receptors is controlled by 
sequestering growth factors (also known as latency) within the interstitium or in the 
circulation (Rifkin et al. 1999). For example, IGF-I and IGF-II (Mohan & Baylink 
2002), transforming growth factor-beta (TGF-β) (Rifkin et al. 1999; Nunes et al. 
1997), and BMPs (Balemans & Van Hul 2002) are linked to specific binding proteins 
that impede the growth factor-receptor interaction through soluble and insoluble 
growth factor-binding protein complexes. Moreover, platelet-derived growth factor 
(PDGF) (LaRochelle et al. 1991), FGF (Sahni et al. 1998) and VEGF (Sahni & 
Francis 2000) can bind to specific extracellular matrix molecules leading to an 
immobilization and inactivation of the growth factors. Their specific functions and 
applications within the field of TE are summarized in table 2. 
Table 2 Representative growth factors in (B)TE (adopted from(Jeffrey et al. 2005)). 
Growth factor Putative function(s) (TE) applications 
BMPs 
Bone, liver development, embryonic 
development 
Spinal fusion, fracture 
healing, dental and 
craniofacial reconstruction 
TGF-β 
Bone formation and resorption, growth 
arrest, metastasis, chondrocyte 
differentiation 
Intervertebral disc 
regeneration, arthritis 
IGFs 
Embryonic and neonatal growth, bone 
matrix mineralization, cartilage 
development and homeostasis 
Cartilage, bone, tendon 
FGFs 
Embryonic development, wound healing, 
bone and cartilage formation, 
enhancement of blood vessels 
Bone, blood vessels 
VEGFs 
Angiogenesis, vessel remodeling and 
repair, vasodilatation, bone formation 
Bone, blood vessels 
PDGF Bone formation, osteoblast chemotaxis 
Ligament and tendon, bone, 
periodontal 
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Besides biochemical stimuli, biomechanical stimuli have significant effects on the 
morphology, cell density, and differentiation of MSCs. These effects are dependent 
on the type, magnitude, and frequency of the applied stimulation (Maul et al. 2011). 
MSC differentiation can be triggered through biophysical signals (e.g. externally 
applied forces, manipulation of the substrate rigidity, topography or geometry of ECM 
patterning), which are sufficient to direct stem cell fate, if combined with minimal or 
suboptimal biochemical induction. Moreover, biophysical induction can also work in 
synergy with soluble biochemical cues (Yim & Sheetz 2012). For example, shear 
stress has been demonstrated to upregulate the expression of endothelial cell-related 
markers and downregulate smooth muscle-related markers in MSCs (Dong et al. 
2009). Further examples are listed in table 3, highlighting the broad field of 
applications for TE using mechanical stimulation. 
Table 3 MSC responses to mechanical stimuli (adopted from (Yim & Sheetz 2012)). 
Cell type Mechanical stimulus Cellular response 
MSC 
Application of forces (cyclic/static), increase in 
cell area, increase in substrate rigidity, random 
nano-topography 
Osteogenic differentiation 
Decrease in cell area, decrease in substrate 
rigidity, inhibition of RhoA pathway 
Chondrogenic/adipogenic 
differentiation 
Application of force (e.g., cyclic strain), 
intermediate substrate rigidity 
Myogenic/smooth muscle 
cell differentiation 
Soft substrate rigidity, anisotropic (line) 
topography 
Neurogenesis 
ASC 
Intermediate substrate rigidity Myogenic differentiation 
RhoA pathway inhibitor Chondrogenic differentiation 
Embryonic 
stem cells 
Anisotropic (line) topography Neuronal differentiation  
Pillar topography Osteogenic differentiation 
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D. Bioreactors for Tissue Engineering 
According to the Oxford Dictionary “bioreactors” are defined as “an apparatus in 
which a biological reaction or process is carried out, especially on an industrial 
scale”. The main functions of bioreactors are to guarantee controlled environmental 
conditions (e.g. pH, CO2 – and oxygen levels, temperature) and controlled nutrition 
and waste removal during the biological process. In order to meet regulatory 
specifications of a product (reproducibility, safety, and quality) bioreactors are 
optimized in terms of automation, reliability, and reproducibility. In the context of 
tissue engineering, bioreactors provide the possibility to control and standardize cell 
cultures and therefore optimize the development of tissue substitutes (Wendt et al. 
2008). 
1. Perfusion bioreactors 
Bioreactors in tissue engineering are essential for in vitro cultivation and maturation 
of engineered tissues. Homogenous cell seeding, enhanced mass transport and 
physiological mechanical loading depict key functions of bioreactor systems in the 
field of TE. Perfusion bioreactors have been demonstrated to improve cell seeding 
(Wendt et al. 2003; Wendt et al. 2006) and accomplish optimal mass transport of 
nutrients throughout a cell seeded scaffold overcoming diffusion limitations (Martin et 
al. 1999). Particularly during cell seeding the performance of a perfusion bioreactor 
system leads to a more efficient and effective seeding when compared to the “static 
seeding” (Vunjak-Novakovic et al. 1999). The perfusion of a cell seeded scaffold 
depicts physiological conditions including shear stress, enhancing cellular 
osteogenesis and mineralization (Gomes et al. 2003). These systems have been 
used in many applications underlining their enormous potential in terms of improved 
proliferation and differentiation capacity as well as mineralized matrix deposition by 
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osteoblasts (Bancroft et al. 2002; Goldstein et al. 2001; Sikavitsas et al. 2005), 
enhanced ECM synthesis by chondrocytes (Davisson et al. 2002; Wendt et al. 2006), 
and the possibility of construct up-scaling (Santoro et al. 2010). Finally, perfusion 
systems enable online-monitoring of metabolites or environmental parameters using 
online biosensors (Santoro et al. 2011; Janssen et al. 2006). Several types of 
perfusion bioreactors have been developed for (B)TE applications (Figure 10), 
including spinner flask (SF), rotating wall vessel (RWV), rotating bed system (RBS), 
hollow-fiber and direct perfusion bioreactors (Rauh et al. 2011; Martin et al. 2004). 
 
 
Figure 10 Perfusion bioreactor systems (Martin et al. 2004). 
Representative perfusion bioreactor systems for TE applications. (a) Spinner flask bioreactors have 
been used for cell seeding into 3D scaffolds and subsequent culture. (b) Hollow-fiber bioreactors 
are used to enhance mass transfer during the culture of highly metabolic and sensitive cell types 
such as hepatocytes. (c) Rotating-wall vessels provide a dynamic culture environment. (d) Direct 
perfusion bioreactors in which medium flows directly through the pores of a scaffold. 
(a) (b) 
(c) 
(d) 
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2. Mechanical bioreactors  
The human body and its organs and tissues are exposed to complex biomechanical 
cues, such as dynamic strains, stresses, fluid flows, electrical currents and 
hydrostatic pressures. These physiological forces are known to play a crucial role in 
in vivo cell physiology. Also in vitro, many studies have been carried out underlining 
the enormous potential to improve or accelerate the generation of functional tissues. 
The appropriate stimulus needed in order to engineer a curtain tissue depends on the 
mechanical, biological, biochemical and structural characteristics of the native tissue 
(Alvarez-Barreto & Sikavitsas 2007). Using bioreactor systems capable to apply one 
or more physiological loading regimes, it has been shown that mechanical 
conditioning in vitro can stimulate ECM production (Démarteau et al. 2003), improve 
structural organization (Niklason et al. 1999), direct cell differentiation (Knothe Tate et 
al. 2008; Matziolis et al. 2011; Altman et al. 2002), enhance specific tissue function 
(Sun et al. 2010), and affect signal pathways (Sanchez et al. 2009; Rubin et al. 
2006). The systems used include bioreactors applying pulsatile fluid flow [vascular 
grafts, heart valves (Niklason & Langer 1997; Thompson et al. 2002)], hydrostatic 
pressure [vascular structures, cartilage (Niklason & Langer 1997; Thompson et al. 
2002; Mizuno et al. 2002)], cyclic strain [blood vessels, bone, ligaments and tendons 
(Seliktar et al. 2000; Neidlinger-Wilke et al. 1994; Winter et al. 2003)], compression 
[cartilage, bone (Démarteau et al. 2003; Sittichokechaiwut et al. 2010; Rath et al. 
2008; Matziolis et al. 2011; Jagodzinski et al. 2008)], shear [cartilage (Schätti et al. 
2011)], electrical current [bone healing (Yonemori et al. 1996; Brighton et al. 2001)] 
and the combination of several stimuli [e.g. shear and compression (Sun et al. 2010; 
Shahin & Doran 2012; Yusoff et al. 2011)]. These studies emphasize that mechanical 
loading/conditioning of engineered tissues has the potential to improve construct 
generation and to lead to more physiological-like engineered tissues. Nevertheless, 
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the understanding about the exact mechanisms driven by various forces (i.e. shear, 
tension, compression and pressure) and loading regimes remain unclear. 
Additionally, the spatial and temporal development of engineered tissues plays a 
crucial role in defining the appropriate mechanical stimuli. Cell-scaffold and cell-ECM 
interactions vary during the maturation process of the tissue and therefore adaptation 
of the loading regimes during construct development might be necessary (van der 
Meulen & Huiskes 2002). 
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E. Thesis outline 
Mechanical stimuli are among the most potent factors acting in the processes of 
remodeling during bone fracture healing and bone development. Exploring the 
benefits of rapid-prototyping, shape-memory-alloys and mechanical loading, this 
thesis aims at the development of an in vitro model for endochondral ossification 
specifically aiming at the introduction of mechanical loading as a potent factor to 
modulate the endochondral process. 
Chapter 1: Interleukin-1β modulates endochondral ossification by human adult bone 
marrow stromal cells 
Inflammatory cytokines, which are present in the environment of the fracture site, are 
important modulators of fracture healing. During endochondral ossification 
interleukin-1β (IL-1β) is a key-cytokine. In this chapter, the effect of IL-1β on 
glycosaminoglycan (GAG) production and BMP-2 expression during chondrogenesis 
and ECM calcification during the hypertrophic phase of in vitro cultures is studied. 
Moreover, the effect of IL-1β treated hypertrophic constructs undergoing remodeling 
upon in vivo implantation is assessed. Taking the modulating effects on 
endochondral ossification of Interleukin-1β into account, a synergistic effect in 
combination with mechanical loading can be hypothesized. 
Chapter 2: Novel perfused compression bioreactor system as an in vitro model to 
investigate fracture healing 
With the purpose of applying mechanical loads on cartilage templates depicting an 
in vitro model of the soft callus during fracture healing, we developed a compression 
bioreactor system capable of applying defined physiological deformations. The 
system was fully validated ensuring its performance reliability in long-term cultures. 
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Mechanically loaded, engineered tissues exhibit a higher degree of maturation as 
compared to unloaded tissues. Therefore the combination of the compression 
bioreactor system with cell seeded collagen-based constructs is exploited to gain 
deeper insight into the process of load-assisted hypertrophic differentiation. This will 
converge in an improved in vitro model of hypertrophic cartilage and therefore 
facilitate the optimization of our fracture healing model. 
Chapter 3: Rapid prototyped porous NiTi scaffolds as bone substitutes 
In order to obtain primary implant stability and high mechanical strength, selective 
laser melting (SLM)-based NiTi constructs are foreseen to be utilized as a backbone 
for hypertrophic cartilage templates. Initially, we demonstrated high biocompatibility 
of NiTi- based constructs. Thereafter, MSC adhesion, proliferation and differentiation 
along the osteogenic lineage were obtained on two-dimensional constructs using 
suitable biochemical stimulators. Porous three-dimensional NiTi scaffolds cultured in 
a standardized perfusion bioreactor system allow for adhesion and proliferation of 
MSC in the same degree as observed on two-dimensional constructs. In combination 
with appropriate biochemical stimulators, we were able to differentiate progenitor 
cells towards committed cells with both osteoblastic and chondroblastic phenotype 
facilitating the mimicry of both routes of ossification, i.e. intramembranous and 
endochondral. Therefore, considering the adhesion, proliferation, and differentiation 
capacity of MSC on SLM-NiTi, this study as well presents the possibility to utilize 3D 
NiTi scaffolds as a cell-free implant material for bone repair. In vivo, small numbers of 
MSC from the blood or bone marrow in the repair site could infiltrate the scaffold, 
adhere to its surface and proliferate. This could result in the colonization of the 
scaffold, subsequent differentiation of MSC down the osteogenic linage, and 
ultimately lead to accelerated osseointegration of the implant. 
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This thesis focuses on revealing the influences of the inflammatory and 
biomechanical environment on fracture calluses in vitro. Here, the established in vitro 
fracture callus model (Scotti et al. 2010; Mumme et al. 2012, chapter 1) was further 
developed through the introduction of mechanical loading, applied through a novel 
compression bioreactor system (chapter 2). This enables to study the effects of 
physiological mechanical loads on fracture calluses (engineered endochondral 
constructs). In order to benefit from these studies, load-bearing NiTi-reinforced 
endochondral constructs have been intended for orthotopic in vivo implantation 
aiming at the development of NiTi-based mechanically active implants. 
Consequently, chapter 3 provides evidences for the potential of SLM-NiTi as a 
scaffold material for bone tissue engineering applications (i.e., in vitro engineering of 
osteogenic grafts) as well as regenerative medicine approaches (i.e., as a cell-free 
implant material).  
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A. General summary 
The processes of bone fracture healing and bone development share certain 
similarities and are affected by mechanical loads, the local microenvironment and 
other factors. In this thesis, an established in vitro fracture callus model (Scotti et al. 
2010; Mumme et al. 2012) was further developed through the introduction of 
mechanical loading. This system allows for the investigation of the effects of 
physiological mechanical loads on fracture calluses (engineered endochondral 
constructs), NiTi-reinforced endochondral constructs and native tissues. Exploring 
the benefits of rapid-prototyping, shape-memory-alloys and mechanical loading the 
introduction of a novel, in vitro model for mechanically modulated endochondral 
ossification is intended. 
Inflammatory cytokines, which are present in the environment of the fracture site, are 
important modulators of fracture healing. Thus, in chapter 1 the effect of IL-1β on 
glycosaminoglycan (GAG) production and BMP-2 expression during chondrogenesis 
and ECM calcification during the hypertrophic phase of in vitro cultures was 
investigated. These constructs depict an in vitro model for fracture calluses and are 
therefore used to investigate the effect of IL-1β on the remodeling process, which 
occurs upon in vivo implantation. It has been demonstrated that IL-1β finely 
modulates early and late events of the endochondral bone formation by MSC. 
Controlling the inflammatory environment could enhance the success of therapeutic 
approaches for the treatment of fractures by resident MSC as well as improve the 
engineering of implantable tissues. 
Secondary bone fracture healing is a physiological process, which leads to functional 
tissue regeneration recapitulating endochondral bone formation. Besides other 
factors, mechanical loading is known to modulate the process of fracture healing. 
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Therefore, in chapter 2 a novel perfused compression bioreactor system (PCB) is 
demonstrated for the investigation of the effect of dynamic mechanical loading on the 
mineralization process of engineered, hypertrophic constructs. The results obtained 
demonstrate that dynamic mechanical loading enhances the maturation process of 
MSC towards late hypertrophic chondrocytes and the mineralization of the 
extracellular matrix.  Moreover, the system possibly allows for the identification of 
suitable loading regimes to accelerate the process of fracture healing.  
In order to improve primary implant stability and to upscale endochondral constructs, 
selective laser melting (SLM)-based NiTi constructs are foreseen to be utilized as a 
backbone for hypertrophic cartilage templates. NiTi alloys possess a unique 
combination of mechanical properties including a relatively low elastic modulus, 
pseudoelasticity, and high damping capacity, matching the properties of bone. 
Hence, in chapter 3, we demonstrated biocompatibility of NiTi-based constructs. 
Moreover, MSC adhesion, proliferation and differentiation along the osteogenic 
lineage were similar to MSC cultured on clinically used Ti. When seeded and cultured 
on porous 3D SLM-NiTi scaffolds, MSC homogeneously colonized the scaffold, and 
following osteogenic induction, filled the scaffold’s pore volume with extracellular 
matrix. The combination of bone-related mechanical properties of SLM-NiTi with its 
cytocompatibility and support of osteogenic properties by MSC highlights its potential 
as a superior bone substitute as compared to Ti. 
In conclusion, this thesis highlights that MSC based chondrogenic and hypertrophic 
constructs depict in vitro models for soft and hard fracture calluses, respectively. This 
constructs are responsive to both inflammatory cytokines (IL-1β modulating early and 
late events of the endochondral bone formation) and dynamic mechanical loading 
(increased degree of maturation of both MSC and ECM). Moreover, it has been 
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shown that the PCB serves as a promising tool for further systematic studies in an 
in vitro setting leading to a reduction of animal experiments within the field. 
Nevertheless, the established models (including mechanically loaded constructs) are 
not capable of supporting load-bearing fracture sites. Therefore, to overcome the lack 
of mechanical stability a NiTi-based approach is intended. SLM-NiTi was shown to be 
biocompatible and MSC do colonize these constructs and differentiate along the 
osteogenic lineage. Using SLM-NiTi scaffolds as a backbone supporting initial load-
bearing, MSC could be used to colonize it and fill the scaffolds pores with a 
chondrogenic and/or hypertrophic ECM. This construct depicts a NiTi-reinforced, 
mechanically stable endochondral implant intended for orthotopic implantation.  
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B. Future perspectives 
As described in Chapter 3, SLM-NiTi constructs depict a promising biomaterial to 
engineer load-bearing constructs, which might be used in several applications. 
Nevertheless, Ni release from NiTi implants remains a significant concern limiting the 
applications due to cytotoxicity (Taira et al. 2000) and hypersensitivity (Jia et al. 
1999; Savarino et al. 1999). Therefore, we investigated the Ni release of SLM-NiTi 
scaffolds in two conditions: loaded (+ML) and non-loaded (-ML). To mimic 
physiological loading conditions, uniaxial dynamic compression was applied 
(sinusoidal loading profile, 100 µm displacement amplitude and a frequency of 8 Hz). 
Samples for Ni release measurements were taken at 24h (690’000 cycles), 1 week 
(4.8 x 106 cycles) and 2 week time points (9.6 x 106 cycles). The amount of released 
Ni ions was assessed by atom absorption spectroscopy (AAS, Perkin Elmer, 
AAnalyst 800, graphite furnace, 232 nm) and is depicted in figure 11.  
Figure 11 Ni release by SLM-NiTi scaffolds. 
Ni release for non-loaded (-ML) and loaded (+ML) NiTi scaffolds. Dashed line depicts cytotoxic Ni 
ion level: 2.35 µg/mL (Taira et al. 2000). 
 
Figure 12 MSC cultured on NiTi scaffolds.Figure 13 Ni release by SLM-NiTi scaffolds. 
Ni release for non-loaded (-ML) and loaded (+ML) NiTi scaffolds. Dashed line depicts cytotoxic Ni 
ion level: 2.35 µg/mL (Taira et al. 2000). 
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Non-loaded SLM-NiTi constructs show minimal Ni ion release. The mechanically 
loaded NiTi scaffolds demonstrated a significantly higher Ni ion release within the first 
24h. Thereafter only small, time-dependent increases were detected. Upon 
application of physiological loads, cracks may form in the titanium oxide layer on the 
NiTi surface. Due to the rupture of the protective oxide layer, Ni ions are released into 
the surrounding environment. The Ni ion concentrations determined in this study 
remain under the cytotoxic level of 2.35 µg/mL (Taira et al. 2000). Surface treatments 
could further improve the inertness of NiTi constructs. Moreover, under in vivo 
conditions, NiTi implants are continuously flushed by the bloodstream minimizing 
local Ni ion concentrations even further. Likewise, MSC have been shown to colonize 
loaded SLM-NiTi scaffolds with no signs of cytotoxicity (Habijan et al. 2011).  
Figure 38 MSC cultured on NiTi scaffolds. 
The upper panel depicts glycosaminoglycans stained with Safranin-O after 3 weeks of 
chondrogenic MSC culture. The lower panel displays mineralized matrix stained with Alizarin 
Red after 5 weeks of hypertrophic MSC culture. 
 
Figure 39 In vivo bone formation capacity of endochondral NiTi constructs.Figure 40 MSC 
cultured on NiTi scaffolds. 
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To further prove the possibility to use SLM-NiTi constructs as biomaterial, the 
differentiation potential of MSC along the endochondral route was investigated. 
Figure 12 demonstrates the capacity of MSC seeded on 3D NiTi scaffolds to undergo 
the process of endochondral ossification. Post chondrogenic induction, MSC 
depicted chondrogenic features including positive Safranin-o staining for GAG and 
large cells in typical lacunae. Following the induction of hypertrophic differentiation, 
the ECM displayed a high degree of mineralization. These observations suggest that 
SLM-NiTi scaffolds as a reinforcing backbone for endochondral constructs depict a 
promising approach to engineer load-bearing, up-scaled constructs enriched with a 
fracture callus-like ECM. 
Moreover, the in vivo bone forming capacity of SLM-NiTi reinforced endochondral 
constructs was assessed. Following an in vitro culture consisting of three weeks of 
chondrogenesis and two weeks of hypertrophic induction, endochondral NiTi 
constructs were implanted ectopically into nude mice. After 12 weeks in vivo, bone 
formation capacity was assessed by means of Hematoxylin and Eosin (H&E) 
staining. 
Figure 64 In vivo bone formation capacity of endochondral NiTi constructs. 
Left image: H&E staining after 12 weeks in vivo period depicting the formation of woven bone 
within the pores of the SLM-NiTi scaffold. Right image: Fluorescence image of the eosin 
stain. Osteocytes are visible as dark spots within the bright woven bone. 
 
Figure 65 Future perspectives.Figure 66 In vivo bone formation capacity of endochondral 
NiTi constructs. 
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Formation of woven bone within the pores of the NiTi scaffolds is depicted 
(Figure 13). Due to the thickness of the histological sections, the acquisition of high 
resolution bright filed images is not trivial. Therefore, fluorescence microscopy was 
performed to further investigate the bone formation. In vivo bone formation occurred 
within the NiTi scaffolds leading to osseointegration (bone formation along the 
implant), dense bone matrix formation (white areas), and osteocyte formation (dark 
spots). The results emphasize the potential of SLM-NiTi as a load-bearing bone 
implant. 
Further possible applications arising from the data presented in the context of this 
thesis are summarized in Figure 14: 
A. The production of personalized SLM-NiTi implants is facilitated through the 
use of computer-tomography data to design patient-specific implant 
geometries and autologous adult mesenchymal stem cells from adipose 
tissue or bone marrow. The cells are cultured on the implants with the 
application of physiological mechanical loads using the compression 
bioreactor system to accelerate the process of matrix production and 
maturation. This will lead to a personalized, load-bearing implant intended 
for dental and/or orthopedic applications. 
B. Using a cell engineering approach, functionalized MSC can be generated, 
which deposit a defined and reproducible matrix and simultaneously carry 
an inducible death cassette (Bourgine et al. 2014). In combination with 
SLM-NiTi, load-bearing off-the-shelf products can be generated. In this 
regard the engineered MSC are intended to produce high amounts of 
chondrogenic/hypertrophic matrix aided by the application of physiological 
mechanical loads. Subsequently, MSC apoptosis is induced leaving behind 
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an implant covered with a defined ECM matrix. This ECM-enriched 
implants can be further processed (e.g. lyophilization) to enable long-term 
storage. 
C. The compression bioreactor system, developed, validated and patented 
(Hoffmann et al. 2014) in the scope of this work, depicts a promising tool 
for several applications not only related to the field of tissue engineering. 
As mentioned previously, it can serve as method used to generate mature 
engineered tissues in vitro using diverse scaffolds with wide ranges of 
mechanical properties. Besides, quality control of engineered and native 
tissues can be performed comparing the mechanical properties to healthy, 
pathological and native tissues. Moreover, the system allows for systematic 
investigations of the influence of mechanical loading on engineered and 
native tissues. This approach could lead to further investigations of the 
underlying mechanisms during mechanically triggered fracture healing and 
tissue maturation processes. 
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